Pharmacoepidemiology and Drug Safety: Vol 28, No 4

I consent to Wiley Online Library’s Terms of Use and processing of my personal data as disclosed in Wiley’s Privacy Policy.I consent to my personal information being transferred outside of the People’s Republic of China as laid out in Wiley’s Privacy Policy.*(Optional) I consent to special offers, newsletter & promotions from Wiley. See Privacy Policy for more details.

Tools

Submit an article

Journal Metrics

Subscribe to this journal

Using Pharmacoepidemiology to Study Biosimilars themed issue

More from this journal

This journal supports the Wiley Research Diversity, Equity & Inclusion statement

Read the statement

Posts by PDS

Pharmacoepidemiology and Drug Safety

Journal list menu

Tools

Follow journal

Pharmacoepidemiology and Drug Safety: Volume 28, Issue 4

ISSUE INFORMATION

Issue Information

REVIEWS

A systematic review of methods for determining cross-sectional active medications using pharmacy databases

The ENCePP Code of Conduct: A best practise for scientific independence and transparency in noninterventional postauthorisation studies

COMMENTARIES

Oseltamivir phosphate—Lifting the restriction on its use to treat teenagers with influenza in Japan

Perinatal deaths after sildenafil treatment of fetal growth restriction raise the issue of safety in randomised clinical trials

Using RWE for Regulatory Decisions

Considerations in characterizing real-world data relevance and quality for regulatory purposes: A commentary

ORIGINAL REPORTS

Personalized benefit-risk assessments combining clinical trial and real-world data provide further insights into which patients may benefit most from therapy: Demonstration for a new oral antiplatelet therapy

Prenatal exposure to non-steroidal anti-inflammatory drugs (NSAIDs) and neurodevelopmental outcomes in children

Statin use and survival in patients with gastric cancer in two independent population-based cohorts

Proton pump inhibitor use and risk of breast cancer, prostate cancer, and malignant melanoma: An Icelandic population-based case-control study

Proton-pump inhibitors and the risk of Clostridium difficile–associated diarrhea in high-risk antibiotics users: A population-based case-crossover study

Does the use of incretin-based medications increase the risk of cancer in patients with type-2 diabetes mellitus?

Use of dipeptidyl peptidase-4 inhibitors and the risk of arthralgia: Population-based cohort and nested case–control studies

Clinical outcomes and risk factors of thromboprophylaxis with rivaroxaban versus aspirin in patients undergoing hip arthroplasty in low-incidence population: A nationwide study in Korea

Safety of a quadrivalent meningococcal conjugate vaccine in healthy subjects aged 9 months to 55 years in Vietnam

Anticipating the effects of restricting high-dose preparations of strong opioids in Australia: A population-based analysis to inform the current policy debate

Exposure to phthalate-containing prescription drugs and the risk of colorectal adenocarcinoma: A Danish nationwide case-control study

Availability of drug at convenient stores is not associated with an increased incidence of their poisoning

A tailor-made approach for causality assessment for ADR reports on drugs and vaccines

BRIEF REPORTS

Secret safety warnings on medicines: A case study of information access requests

Use and safety of disease-modifying therapy in pregnant women with multiple sclerosis

ISSUE INFORMATION

Issue Information

Tools

More from this journal

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Pharmacoepidemiology and Drug Safety

Journal list menu

Tools

Follow journal

Pharmacoepidemiology and Drug Safety: Volume 28, Issue 4

Download PDFs

ISSUE INFORMATION

Issue Information

REVIEWS

A systematic review of methods for determining cross-sectional active medications using pharmacy databases

The ENCePP Code of Conduct: A best practise for scientific independence and transparency in noninterventional postauthorisation studies

COMMENTARIES

Oseltamivir phosphate—Lifting the restriction on its use to treat teenagers with influenza in Japan

Perinatal deaths after sildenafil treatment of fetal growth restriction raise the issue of safety in randomised clinical trials

Using RWE for Regulatory Decisions

Considerations in characterizing real-world data relevance and quality for regulatory purposes: A commentary

ORIGINAL REPORTS

Personalized benefit-risk assessments combining clinical trial and real-world data provide further insights into which patients may benefit most from therapy: Demonstration for a new oral antiplatelet therapy

Prenatal exposure to non-steroidal anti-inflammatory drugs (NSAIDs) and neurodevelopmental outcomes in children

Statin use and survival in patients with gastric cancer in two independent population-based cohorts

Proton pump inhibitor use and risk of breast cancer, prostate cancer, and malignant melanoma: An Icelandic population-based case-control study

Proton-pump inhibitors and the risk of Clostridium difficile–associated diarrhea in high-risk antibiotics users: A population-based case-crossover study

Does the use of incretin-based medications increase the risk of cancer in patients with type-2 diabetes mellitus?

Use of dipeptidyl peptidase-4 inhibitors and the risk of arthralgia: Population-based cohort and nested case–control studies

Clinical outcomes and risk factors of thromboprophylaxis with rivaroxaban versus aspirin in patients undergoing hip arthroplasty in low-incidence population: A nationwide study in Korea

Safety of a quadrivalent meningococcal conjugate vaccine in healthy subjects aged 9 months to 55 years in Vietnam

Anticipating the effects of restricting high-dose preparations of strong opioids in Australia: A population-based analysis to inform the current policy debate

Exposure to phthalate-containing prescription drugs and the risk of colorectal adenocarcinoma: A Danish nationwide case-control study

Availability of drug at convenient stores is not associated with an increased incidence of their poisoning

A tailor-made approach for causality assessment for ADR reports on drugs and vaccines

BRIEF REPORTS

Secret safety warnings on medicines: A case study of information access requests

Use and safety of disease-modifying therapy in pregnant women with multiple sclerosis

ISSUE INFORMATION

Issue Information

Sign up for email alerts

Tools

More from this journal